期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

贝伐单抗治疗复发或晚期转移性乳腺癌的临床价值 被引量：2

Clinical value of Bevacizumab for recurrent or advanced metastatic breast cancer
下载PDF
导出
摘要 分子靶向治疗是当前乳腺癌治疗领域研究的热点,贝伐单抗是第一个获得批准上市的抑制肿瘤血管生成的药,也是继抗Her-2靶向治疗领域之后另一全新领域。抗肿瘤血管靶向治疗领域;但目前关于贝伐单抗用于乳腺癌的有效性及安全性具有争议。本文汇总国内外关于贝伐单抗治疗乳腺癌的最新研究进展,并评价其临床使用价值。 Molecular targeted theraPy is the hotsPot in research of breast cancer. Bevacizumab is listed on the first aPProval of inhibiting tumor angiogenesis drug,is the resistance to targeted its eer - 2 after another new field - the treatment of anti - tumor vascular targeted theraPy field. But the clinical value of Bevacizumab for advanced or meta-static breast cancer are hot disPuting. We summarize the latest Progress of bevacizumab treatment for breast cancer at home and abroad,to evaluate the clinical value of Bevacizumab.
作者 余宗艳 齐宇红 梁军
机构地区 第四军医大学唐都医院放疗科
出处 《现代肿瘤医学》 CAS 2014年第5期1206-1208,共3页 Journal of Modern Oncology
关键词 乳腺癌 靶向治疗 贝伐单抗 紫杉醇 breast cancer targeted theraPy Bevacizumab Paclitaxel
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1刘健,李学瑞.化疗联合贝伐单抗在HER2阴性转移性乳腺癌一线治疗的研究[J].循证医学,2012,12(3):150-152. 被引量：1
  • 2吴小艳.贝伐珠单抗的转移性乳腺癌适应证被撤销[J].药物不良反应杂志,2011,13(6):400-401. 被引量：1
  • 3Ardavanis A, Doufexis D, Kount ourakis P, et al. Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks : a retrospective case review study [ J ]. BMC Canc er,2009,9(2) :332 -338.
  • 4Morishita A, Mitsuhashi S, Fujisawa F. Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a ease report [ J ]. Gan To Kagaku Ryoho,2013,40(6) :761 -764.
  • 5Brufsky A, Hoelzer K, Beck T, et al. A randomized phase II study of paclitaxel and bevacizumab with and without gemeitabine as first - line treatment for metastatic breast cancer[ J]. Clin Breast Cancer, 2011,11(4) :211 -220.
  • 6Huijuan Qiu,Wenzhuo He, Chenxi Yin, et al. The efficacy and its related issues of combination of bevacizumab and taxanes - based regimens in Chinese patients with metastatic breast cancer[ Jl Chi- nese - German J Clin Onco1,2012,11 (10) :223 - 225.
  • 7Ishizuna K, Ninomiya J, Kojima M. Paclitaxel - resistant advanced recurrent breast cancer :a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case report[ J]. BMC Res Notes,2013,6( 1 ) :254.
  • 8黎小妍,张二红,曲彩红,张平.贝伐珠单抗联合化疗一线治疗转移性乳腺癌的Meta分析[J].中华肿瘤防治杂志,2012,19(13):1020-1024. 被引量：2
  • 9Seidman AD, Conlin AK, Bach A. Randomized phase II trial of weekly vs every 2 weeks vs every 3 weeks nanoparticie albumin - bound paclitaxel with bevacizumab as first - line chemotherapy for metastatic breast cancer[ J]. Clin Breast Cancer,2013,13 (4) :239 - 246.
  • 10Rugo HS,Campone M, Amadori D,et al. A randomized, phase II, three - arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first - line therapy for metastatic breast cancer [ J ]. Breast Cancer Res Treat,2013,139 (2) :411 - 419.

二级参考文献29

  • 1黄红艳,江泽飞,王涛,张少华,边莉,曹阳,吴世凯,宋三泰.贝伐珠单抗联合多西他赛治疗Her-2阴性复发转移性乳腺癌的疗效观察[J].中国癌症杂志,2011,21(3):220-224. 被引量：18
  • 2江泽飞,王涛.乳腺癌治疗的基本原则和新动向—2006年国际和中国乳腺癌治疗指南解读[J].临床肿瘤学杂志,2006,11(8):561-566. 被引量：20
  • 3毕晔,边莉,黄椠,郑刚,岳金波,左文述.我国乳腺癌热点问题研究的现状分析[J].中华肿瘤防治杂志,2006,13(16):1205-1211. 被引量：35
  • 4Gibb WRJ,Luthert RJ,Janota I,et al. Cortical lewy body dementia:clinical features and classification. J Neurol Neurosurg Psychiatry,1992,52(2) :182-192
  • 5Brown DF. Lewy body dementia. Ann Med,1999,31(3) :188-196
  • 6McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies(DLB): report of the consortium on DLB international workshop.Neurology, 1996,47 ( 5 ): 1113-1124
  • 7McKeith IG, Ballard CG, Perry RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with lewy bodies.Neurology ,2000 ,54 ( 5 ): 1050-1058
  • 8BalLard C, Holmes C, McKeith I, et al. Psychiatric morbidity in dementia with lewy bodies:a prospective clinical and neuropathological comparative study with Alzheimer′s disease. Am J Psychiat, 1999,156(7) :1039-1045
  • 9Fermn TJ, Boeve BF, Smith GE, Silber MH, et al. REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology, 1999,52 ( 5 ) :951-957
  • 10Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with lewy bodies and Alzheimer′s disease. Neurology, 1998,51 ( 1 ) :125-130

共引文献18

同被引文献24

二级引证文献9

现代肿瘤医学
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部